Translate
Transnasal endoscopy (TNE) is a procedure where a thin, flexible endoscope is inserted through the nose and down the throat to examine the oesophagus, stomach, and the first part of the small intestine.
It was recently launched at the CDC, with three patients benefitting from it in its first day. The eventual aim is to gradually increase to four lists a week, with eight patients being seen per list.
While the service is already available at other Royal Free London (RFL) sites, bringing it to the CDC helps to free up capacity in busier hospital environments, and allows patients to access diagnostics closer to their homes.
Dita Chaloupkova, lead advanced clinical endoscopist at RFL, led on developing the service and explained that TNE fits well within community settings like the CDCs, which are designed to provide a wide range of diagnostic services outside conventional hospital environments.
"The service improves accessibility in upper gastrointestinal diagnostics, and eliminates the need for sedation and prolonged recovery," Dita said.
“A dedicated team have been recruited to offer this brilliant service, who benefitted from training provided by Royal Free Hospital colleagues, who they remain in close contact with.”
TNE offers many advantages over traditional, oral endoscopy. Patients typically experience less gagging and discomfort, can talk during the procedure, and require no sedation, leading to quicker recovery and reduced costs.
Andrew Millar, consultant gastroenterologist highlighted the safety and comfort of the procedure, noting that patient selection is important.
“It is a well-tolerated procedure for most, but there are some patients who may need an alternative approach,” Andrew said. “Having the choice of transnasal endoscopy allows patients to go home quickly and carry on with their normal day.
“The service is also a testament to the strong collaboration with our colleagues across the Royal Free Hospital, North Middlesex University Hospital and Chase Farm Hospital. Thank you to everyone who supported us.”
Looking ahead, the team plans to expand the service to provide a one-stop clinic for patients with suspected upper GI cancer, further reducing the need for travel to hospital sites and streamlining diagnostic pathways.
